OPTIPRES EYE DROPS contains Netarsudil, which belongs to the group of medicines known as Rho Kinase Inhibitor. OPTIPRES EYE DROPS is indicated for reduction of elevated intraocular pressure in adult patients with primary open-angle glaucoma or ocular hypertension.
Primary open-angle glaucoma is a type of glaucoma that develops over a period of time due to clogging of drainage channels of the eye. Glaucoma is an irreversible and progressive condition in which the optic nerve gets damaged due to several reasons, such as increased pressure caused by fluid buildup in the front region of the eye. Ocular hypertension can be defined as high intraocular (inside the eye) pressure due to disturbance in balance between production and outflow of aqueous humour (fluid inside the eye).
Inform your doctor before using OPTIPRES EYE DROPS if you have trauma to the eye, planned eye surgery, dry eyes, concurrent eye disease, or if you have ocular epithelial surface disruption, as the risk of bacterial keratitis (bacterial infection of the outer layer of the eye) is increased in such cases.
OPTIPRES EYE DROPS is not recommended for use in pregnant women unless clearly necessary. Consult your doctor before using. OPTIPRES EYE DROPS should be used with caution in breast-feeding women. Consult your doctor before using it.
OPTIPRES EYE DROPS is not recommended for use in children and adolescents under 18 years of age. Consult your doctor before using it.
If you wear contact lenses, they should be removed prior to instillation of this medicine and can be reinserted 15 minutes following its administration.
OPTIPRES EYE DROPS may cause some side effects such as conjunctival hyperaemia (dilation of vessels of conjunctiva due to inflammation), corneal verticillate (condition in which corneal deposits form a faint golden-brown whorl pattern), conjunctival haemorrhage, instillation site pain, and erythema. Consult your doctor immediately in case any of the above side effects worsen.
No content available
